tetano
Editor, Senior Moderator
Arch Acad Emerg Med
. 2020 Apr 21;8(1):e54.
eCollection 2020.
Cross-Protection Induced by Encephalitis Vaccines Against COVID-19 Might Be a Reason for Relatively Lower Mortality Rate in Some Countries
Shojiro Katoh[SUP] 1 2 [/SUP], Toshihiko Obayashi[SUP] 2 [/SUP], Jegatheesan Saravana Ganesh[SUP] 3 [/SUP], Masaru Iwasaki[SUP] 4 [/SUP], Senthilkumar Preethy[SUP] 5 [/SUP], Samuel Jk Abraham[SUP] 4 6 [/SUP]
Affiliations
Abstract
COronaVIrus Disease 2019 (COVID-19) is an on-going pandemic attributed to a novel virus named SARS-CoV-2. Comparing the statistics of incidence and death rates between nations reveals that there is discrepancy amongst countries in these regards, even between countries that share borders. We herein present information from the literature indicating how cross-protection against COVID-19 conferred by the encephalitis vaccine could be the reason for lower fatality rate in the countries where immunization against encephalitis is widespread or included in national programs. This may pave the way for arriving at efficient prevention strategies as well as vaccine development.
. 2020 Apr 21;8(1):e54.
eCollection 2020.
Cross-Protection Induced by Encephalitis Vaccines Against COVID-19 Might Be a Reason for Relatively Lower Mortality Rate in Some Countries
Shojiro Katoh[SUP] 1 2 [/SUP], Toshihiko Obayashi[SUP] 2 [/SUP], Jegatheesan Saravana Ganesh[SUP] 3 [/SUP], Masaru Iwasaki[SUP] 4 [/SUP], Senthilkumar Preethy[SUP] 5 [/SUP], Samuel Jk Abraham[SUP] 4 6 [/SUP]
Affiliations
- PMID: 32440665
Abstract
COronaVIrus Disease 2019 (COVID-19) is an on-going pandemic attributed to a novel virus named SARS-CoV-2. Comparing the statistics of incidence and death rates between nations reveals that there is discrepancy amongst countries in these regards, even between countries that share borders. We herein present information from the literature indicating how cross-protection against COVID-19 conferred by the encephalitis vaccine could be the reason for lower fatality rate in the countries where immunization against encephalitis is widespread or included in national programs. This may pave the way for arriving at efficient prevention strategies as well as vaccine development.